MeiraGTx Holdings (MGTX) Cash from Operations Growth (3y) (2020 - 2025)
MeiraGTx Holdings (MGTX) Cash from Operations Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn | 34.32% |
| 10 | MeiraGTx Holdings | 995.73 Mn | 929.79 Mn | - | 69.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.46% |
| Sep 30, 2025 | 16.16% |
| Jun 30, 2025 | -16.51% |
| Mar 31, 2025 | -64.30% |
| Dec 31, 2024 | -47.92% |
| Sep 30, 2024 | -13.35% |
| Jun 30, 2024 | 2.91% |
| Mar 31, 2024 | -82.15% |
| Dec 31, 2023 | 21.05% |
| Sep 30, 2023 | -38.74% |
| Jun 30, 2023 | -31.09% |
| Mar 31, 2023 | -44.53% |
| Dec 31, 2022 | 9.53% |
| Sep 30, 2022 | -4.04% |
| Jun 30, 2022 | -8.54% |
| Mar 31, 2022 | -28.08% |
| Dec 31, 2021 | 53.85% |
| Sep 30, 2021 | -16.05% |
| Jun 30, 2021 | -3.77% |
| Mar 31, 2021 | 36.12% |